Hep Talk

After nearly three decades of entrenched opposition to funding programs that allow drug users to obtain free sterile syringes, the U.S. Congress in January...

Coffee Talk Two studies shed light on HCV prevention & treatment by Larry Buhl A study on the long-term infectiousness of the hepatitis C virus (HCV) has...

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

It is well known that people with hepatitis C virus (HCV) are at risk for liver damage, but the results of two new studies...

Race to the Cure Who are the biggest players now in eradicating hepatitis C? by Larry Buhl Beyond the implementation of the Affordable Care Act, one of...

CDC Recommends Hepatitis C Testing for All Boomers by Larry Buhl For years CDC guidelines called for hepatitis C (HCV) testing when someone has known risk factors,...

Cash Crisis How a lack of local prevention dollars could lead to more viral hepatitis outbreaks by Larry Buhl A series of hepatitis A outbreaks has erupted...

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...

Changing the Conversation A new storytelling campaign puts a human face on hep B by Larry Buhl Healthcare professionals agree that stigma around hepatitis is the biggest...

What can we do to address the obstacles to HCV treatment? by Larry Buhl Hepatitis C (HCV) is a “silent killer” in more ways than one....